Cargando…
Ophiasis treated with dupilumab
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413662/ https://www.ncbi.nlm.nih.gov/pubmed/34504924 http://dx.doi.org/10.1016/j.jdcr.2021.07.029 |
| _version_ | 1783747673064472576 |
|---|---|
| author | Abercrombie, McKenna Aleshaki, Joseph Fivenson, David |
| author_facet | Abercrombie, McKenna Aleshaki, Joseph Fivenson, David |
| author_sort | Abercrombie, McKenna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8413662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84136622021-09-08 Ophiasis treated with dupilumab Abercrombie, McKenna Aleshaki, Joseph Fivenson, David JAAD Case Rep Case Report Elsevier 2021-08-19 /pmc/articles/PMC8413662/ /pubmed/34504924 http://dx.doi.org/10.1016/j.jdcr.2021.07.029 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Abercrombie, McKenna Aleshaki, Joseph Fivenson, David Ophiasis treated with dupilumab |
| title | Ophiasis treated with dupilumab |
| title_full | Ophiasis treated with dupilumab |
| title_fullStr | Ophiasis treated with dupilumab |
| title_full_unstemmed | Ophiasis treated with dupilumab |
| title_short | Ophiasis treated with dupilumab |
| title_sort | ophiasis treated with dupilumab |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413662/ https://www.ncbi.nlm.nih.gov/pubmed/34504924 http://dx.doi.org/10.1016/j.jdcr.2021.07.029 |
| work_keys_str_mv | AT abercrombiemckenna ophiasistreatedwithdupilumab AT aleshakijoseph ophiasistreatedwithdupilumab AT fivensondavid ophiasistreatedwithdupilumab |